JNJ 26854165 50mg
JNJ-26854165 is one of p53-activating agents and synergizes with AraC or doxorubicin to induce p53-mediated apoptosis and may provide a novel therapeutic approach for the treatment of acute leukemias.
| Trivial name | JNJ 26854165 50mg |
| Catalog Number | A10491-50 |
| Alternative Name(s) | N-[2-(1H-Indol-3-yl)ethyl]-N'-(4-pyridinyl)-1,4-benzenediamine |
| Molecular Formula | C21H20N4 |
| CAS# | 881202-45-5 |
| SMILES | C1=CC=C2C(=C1)C(=CN2)CCNC3=CC=C(C=C3)NC4=CC=NC=C4 |
| Size | 50mg |
| Supplier Page | http://www.adooq.com/jnj-26854165.html |